Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer. Issue 3 (1st February 2016)

• Record Type: Journal Article
• Authors: Xu, Jimmy P.; Branson, Jeffrey D.; Lawrence, Rae; Cocklin, Simon
• Is Part Of: Bioorganic & medicinal chemistry letters. Volume 26:Issue 3(2016)
• Page Start: 824
• Page End: 828
• Publication Date: 2016-02-01
• Subjects: Computer-aided drug design -- Field-based virtual screening -- HIV-1 capsid protein -- Antiviral -- Surface plasmon resonance; Bioorganic chemistry -- Periodicals; Pharmaceutical chemistry -- Periodicals; 572
• DOI: 10.1016/j.bmcl.2015.12.087
• Languages: English
• ISSNs: 0960-894X

Abstract

Graphical abstract: Abstract: The HIV-1 CA protein is an attractive therapeutic target for the development of new antivirals. An inter-protomer pocket within the hexamer configuration of the CA, which is a binding site for key host dependency factors, is an especially appealing region for small molecule targeting. Using a field-based pharmacophore derived from an inhibitor known to interact with this region, coupled to biochemical and biological assessment, we have identified a new compound that inhibits HIV-1 infection and that targets the assembled CA hexamer.